title: An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
abstract: Antibodies to a ganglioside complex consisting of GM1 and GalNAc-GD1a (GM1/GalNAc-GD1a) are found in sera from patients with Guillain-Barré syndrome (GBS). To elucidate the clinical significance of anti-GM1/GalNAc-GD1a antibodies in GBS, clinical features of 58 GBS patients with IgG anti-GM1/GalNAc-GD1a antibodies confirmed by enzyme-linked immunosorbent assay and thin layer chromatography immunostaining were analyzed. Compared to GBS patients without anti-GM1/GalNAc-GD1a antibodies, anti-GM1/GalNAc-GD1a-positive patients more frequently had a preceding respiratory infection (n=38, 66%, p<0.01) and were characterized by infrequency of cranial nerve deficits (n=9, 16%, p<0.01) and sensory disturbances (n=26, 45%, p<0.01). Of the 28 anti-GM1/GalNAc-GD1a-positive patients for whom electrophysiological data were available, 14 had conduction blocks (CBs) at intermediate segments of motor nerves, which were not followed by evident remyelination. Eight of 10 bedridden cases were able to walk independently within one month after the nadir. These results show that the presence of anti-GM1/GalNAc-GD1a antibodies correlated with pure motor GBS characterized by antecedent respiratory infection, fewer cranial nerve deficits, and CBs at intermediate sites of motor nerves. The CB may be generated through alteration of the regulatory function of sodium channels in the nodal axolemma.
authors.affiliation: Division of Neurology, Department of Internal Medicine 3, National Defense Medical College, Tokorozawa, Saitama, 359-8513, Japan.
authors.forename: Go
authors.initials: G
authors.lastname: Ogawa
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Kaida
authors.forename: Motoi
authors.initials: M
authors.lastname: Kuwahara
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Kimura
authors.forename: Keiko
authors.initials: K
authors.lastname: Kamakura
authors.forename: Susumu
authors.initials: S
authors.lastname: Kusunoki
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood*; D003391:Cranial Nerves / Q000503:physiopathology*; D004558:Electric Stimulation; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005677:G(M1) Ganglioside / Q000276:immunology*; D005732:Gangliosides / Q000276:immunology*; D020275:Guillain-Barre Syndrome / Q000097:blood / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction / Q000502:physiology; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000906:Antibodies; D005732:Gangliosides; C021298:ganglioside, GD1a; D005677:G(M1) Ganglioside